Insider Trading & Executive Data
Start Free Trial
22 insider trades in the last year. Go beyond summary counts with transaction-level detail, compensation intelligence, and institutional ownership context.
Omega Flex Inc. is a single‑segment manufacturer of proprietary flexible metal hose, fittings and accessories (TracPipe®, CounterStrike®, DoubleTrac®, DEF‑Trac®, MediTrac®) used primarily in residential and commercial fuel gas, DEF and medical gas systems. The business is concentrated in North America with manufacturing in Exton, PA; Houston, TX; and Banbury, U.K., and it sells mainly through distributors, wholesalers and OEMs on a purchase‑order/resale basis. The company emphasizes product differentiation via a high‑speed proprietary manufacturing process, a large IP portfolio and UL/industry certifications that drive code acceptance and replacement of rigid piping. Omega Flex is relatively small and lean (~175 employees), highly cash‑generative with strong gross margins (~61%), but sensitive to housing starts, commodity costs, distributor concentration and product‑liability/regulatory risk.
Compensation is likely tied to short‑term financial metrics (unit volumes, net sales and operating profit) and liquidity measures (free cash flow/dividend capacity) given the company’s PO‑driven sales, high gross margins and emphasis on cash generation. Management commentary and the MD&A show incentive compensation is material and seasonally paid (one‑time payments early in the year), and the company discloses stock‑based and phantom stock programs—so pay mixes probably include cash bonuses, deferred/phantom equity and some stock‑based awards. Product development and certification milestones (e.g., MediTrac approvals), product‑liability reserve trends and cost control (engineering and selling expenses) are likely performance levers for awards, and pending litigation/insurance outcomes could justify vesting deferral or clawback provisions. Given the firm’s small size, concentrated customer relationships and conservative balance sheet, executive pay programs are likely calibrated to preserve liquidity while rewarding margin and safety/certification achievements.
Insider trading patterns at Omega Flex may cluster around seasonal incentive payments (historically early‑year cash payouts), corporate catalysts (product certifications, MediTrac launches), litigation updates and housing‑market datapoints that drive unit volumes and distributor demand. The company’s relatively small float and concentrated customer exposure mean insider transactions can move the stock more than at larger peers, and phantom stock or cash‑settled awards may prompt sales for liquidity rather than signaling negative views. Standard regulatory considerations apply: Section 16 reporting (Form 3/4/5), potential 10b5‑1 plans and blackout windows around earnings/certification announcements; additionally, material developments in product‑liability litigation or significant changes in distributor relationships should be watched closely as likely drivers of both insider activity and disclosure risk.